arivis becomes partner of the BMBF Project CordiLux

If an already admitted drug is withdrawn from sale, this is mostly due to its harmful cardiological effects.
In the BMBF project CordiLux, the medical faculty of Saarland University and a corporate consortium, including arivis GmbH, is searching for ways of early detection of drugs that are potentially harmul to the heart. Therefore, they use optical devices that are able to measure the secondary effects on heart cells with the help of light signals.

Press release from the Federal Ministry of Education and Research (BMBF), project group Research Jear 2011
News from the focus of research, BMBF Project "CordiLux"